Skip to main content
NCBI home page
Thorax logoLink to Thorax
editorial
. 1993 Dec;48(12):1196–1199. doi: 10.1136/thx.48.12.1196

Vasodilators in pulmonary hypertension.

A Peacock
PMCID: PMC464966  PMID: 8303622

Full text

PDF
1196

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adnot S., Raffestin B., Eddahibi S., Braquet P., Chabrier P. E. Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J Clin Invest. 1991 Jan;87(1):155–162. doi: 10.1172/JCI114965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brown S. E., Linden G. S., King R. R., Blair G. P., Stansbury D. W., Light R. W. Effects of verapamil on pulmonary haemodynamics during hypoxaemia, at rest, and during exercise in patients with chronic obstructive pulmonary disease. Thorax. 1983 Nov;38(11):840–844. doi: 10.1136/thx.38.11.840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chen G., Suzuki H., Weston A. H. Acetylcholine releases endothelium-derived hyperpolarizing factor and EDRF from rat blood vessels. Br J Pharmacol. 1988 Dec;95(4):1165–1174. doi: 10.1111/j.1476-5381.1988.tb11752.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cooper R., Ghali J., Simmons B. E., Castaner A. Elevated pulmonary artery pressure. An independent predictor of mortality. Chest. 1991 Jan;99(1):112–120. doi: 10.1378/chest.99.1.112. [DOI] [PubMed] [Google Scholar]
  5. Dantzker D. R., Bower J. S. Partial reversibility of chronic pulmonary hypertension caused by pulmonary thromboembolic disease. Am Rev Respir Dis. 1981 Aug;124(2):129–131. doi: 10.1164/arrd.1981.124.2.129. [DOI] [PubMed] [Google Scholar]
  6. Demiryurek A. T., Wadsworth R. M., Kane K. A., Peacock A. J. The role of endothelium in hypoxic constriction of human pulmonary artery rings. Am Rev Respir Dis. 1993 Feb;147(2):283–290. doi: 10.1164/ajrccm/147.2.283. [DOI] [PubMed] [Google Scholar]
  7. Evans T. W., Waterhouse J., Finlay M., Suggett A. J., Howard P. The effects of long term methyldopa in patients with hypoxic cor pulmonale. Br J Dis Chest. 1988 Oct;82(4):405–413. doi: 10.1016/0007-0971(88)90096-4. [DOI] [PubMed] [Google Scholar]
  8. Fletcher E. C., Levin D. C. Cardiopulmonary hemodynamics during sleep in subjects with chronic obstructive pulmonary disease. The effect of short- and long-term oxygen. Chest. 1984 Jan;85(1):6–14. doi: 10.1378/chest.85.1.6. [DOI] [PubMed] [Google Scholar]
  9. Frostell C., Fratacci M. D., Wain J. C., Jones R., Zapol W. M. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation. 1991 Jun;83(6):2038–2047. doi: 10.1161/01.cir.83.6.2038. [DOI] [PubMed] [Google Scholar]
  10. Higenbottam T., Wheeldon D., Wells F., Wallwork J. Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin). Lancet. 1984 May 12;1(8385):1046–1047. doi: 10.1016/s0140-6736(84)91452-1. [DOI] [PubMed] [Google Scholar]
  11. Keller C. A., Shepard J. W., Jr, Chun D. S., Dolan G. F., Vasquez P., Minh V. D. Effects of hydralazine on hemodynamics, ventilation, and gas exchange in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Am Rev Respir Dis. 1984 Oct;130(4):606–611. doi: 10.1164/arrd.1984.130.4.606. [DOI] [PubMed] [Google Scholar]
  12. Kinsella J. P., Neish S. R., Shaffer E., Abman S. H. Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn. Lancet. 1992 Oct 3;340(8823):819–820. doi: 10.1016/0140-6736(92)92687-b. [DOI] [PubMed] [Google Scholar]
  13. Light R. W., Mintz H. M., Linden G. S., Brown S. E. Hemodynamics of patients with severe chronic obstructive pulmonary disease during progressive upright exercise. Am Rev Respir Dis. 1984 Sep;130(3):391–395. doi: 10.1164/arrd.1984.130.3.391. [DOI] [PubMed] [Google Scholar]
  14. Morgan J. M., Griffiths M., du Bois R. M., Evans T. W. Hypoxic pulmonary vasoconstriction in systemic sclerosis and primary pulmonary hypertension. Chest. 1991 Mar;99(3):551–556. doi: 10.1378/chest.99.3.551. [DOI] [PubMed] [Google Scholar]
  15. Morgan J. M., McCormack D. G., Griffiths M. J., Morgan C. J., Barnes P. J., Evans T. W. Adenosine as a vasodilator in primary pulmonary hypertension. Circulation. 1991 Sep;84(3):1145–1149. doi: 10.1161/01.cir.84.3.1145. [DOI] [PubMed] [Google Scholar]
  16. Muramoto A., Caldwell J., Albert R. K., Lakshminarayan S., Butler J. Nifedipine dilates the pulmonary vasculature without producing symptomatic systemic hypotension in upright resting and exercising patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease. Am Rev Respir Dis. 1985 Nov;132(5):963–966. doi: 10.1164/arrd.1985.132.5.963. [DOI] [PubMed] [Google Scholar]
  17. Peacock A. J., Matthews A. Transpulmonary angiotensin II formation and pulmonary haemodynamics in stable hypoxic lung disease: the effect of captopril. Respir Med. 1992 Jan;86(1):21–26. doi: 10.1016/s0954-6111(06)80143-5. [DOI] [PubMed] [Google Scholar]
  18. Peacock A., Busst C., Dawkins K., Denison D. M. Response of pulmonary circulation to oral pirbuterol in chronic airflow obstruction. Br Med J (Clin Res Ed) 1983 Oct 22;287(6400):1178–1180. doi: 10.1136/bmj.287.6400.1178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Pepke-Zaba J., Higenbottam T. W., Dinh-Xuan A. T., Stone D., Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet. 1991 Nov 9;338(8776):1173–1174. doi: 10.1016/0140-6736(91)92033-x. [DOI] [PubMed] [Google Scholar]
  20. Rich S., Kaufmann E. High dose titration of calcium channel blocking agents for primary pulmonary hypertension: guidelines for short-term drug testing. J Am Coll Cardiol. 1991 Nov 1;18(5):1323–1327. doi: 10.1016/0735-1097(91)90556-o. [DOI] [PubMed] [Google Scholar]
  21. Rich S., Kaufmann E., Levy P. S. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med. 1992 Jul 9;327(2):76–81. doi: 10.1056/NEJM199207093270203. [DOI] [PubMed] [Google Scholar]
  22. Rich S., Martinez J., Lam W., Levy P. S., Rosen K. M. Reassessment of the effects of vasodilator drugs in primary pulmonary hypertension: guidelines for determining a pulmonary vasodilator response. Am Heart J. 1983 Jan;105(1):119–127. doi: 10.1016/0002-8703(83)90288-0. [DOI] [PubMed] [Google Scholar]
  23. Robertson B. E., Warren J. B., Nye P. C. Inhibition of nitric oxide synthesis potentiates hypoxic vasoconstriction in isolated rat lungs. Exp Physiol. 1990 Mar;75(2):255–257. doi: 10.1113/expphysiol.1990.sp003399. [DOI] [PubMed] [Google Scholar]
  24. Rubin L. J., Mendoza J., Hood M., McGoon M., Barst R., Williams W. B., Diehl J. H., Crow J., Long W. Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial. Ann Intern Med. 1990 Apr 1;112(7):485–491. doi: 10.7326/0003-4819-112-7-485. [DOI] [PubMed] [Google Scholar]
  25. Simonneau G., Escourrou P., Duroux P., Lockhart A. Inhibition of hypoxic pulmonary vasoconstriction by nifedipine. N Engl J Med. 1981 Jun 25;304(26):1582–1585. doi: 10.1056/NEJM198106253042606. [DOI] [PubMed] [Google Scholar]
  26. Vergnon J. M., Barthélémy J. C., Riffat J., Boissier C., Claudy A., Emonot A. Raynaud's phenomenon of the lung. A reality both in primary and secondary Raynaud syndrome. Chest. 1992 May;101(5):1312–1317. doi: 10.1378/chest.101.5.1312. [DOI] [PubMed] [Google Scholar]
  27. Voelkel N. F. Mechanisms of hypoxic pulmonary vasoconstriction. Am Rev Respir Dis. 1986 Jun;133(6):1186–1195. doi: 10.1164/arrd.1986.133.6.1186. [DOI] [PubMed] [Google Scholar]
  28. Weitzenblum E., Sautegeau A., Ehrhart M., Mammosser M., Pelletier A. Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1985 Apr;131(4):493–498. doi: 10.1164/arrd.1985.131.4.493. [DOI] [PubMed] [Google Scholar]
  29. Winter R. J., Langford J. A., Rudd R. M. Effects of oral and inhaled salbutamol and oral pirbuterol on right and left ventricular function in chronic bronchitis. Br Med J (Clin Res Ed) 1984 Mar 17;288(6420):824–825. doi: 10.1136/bmj.288.6420.824. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES